Emergent BioSolutions says it can make 1 billion Covid vaccine doses annually
Emergent BioSolutions, a behind-the-scenes player in the U.S. coronavirus vaccine program, has built capacity to produce vaccines from AstraZeneca and Johnson & Johnson around the clock. "We are operating at … Read More
